benzonatate
1 Inquiries
104-31-4
shanghai
25kge/ea
2023-12-29
BBiochemicals,Peptides,Silicones,Pharmaceuticals,Building blocks,Intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Benzonatate
Other Name:Benzoic acid,4-(butylamino)-,3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester;Benzoic acid,p-(butylamino)-,2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl ester;Benzoic acid,p-(butylamino)-,ester with 2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-ol;Benzonatate;Benzononantin;Benzononatine;Tessalon;Tessalon-Ciba;Ventussin-Loz;Exangit;KM 65;Tesalon;Tessalin;Ventussin;2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl 4-(butylamino)benzoate
CAS No.:104-31-4
Molecular Formula:C30H53NO11
InChIKeys:InChIKey=MAFMQEKGGFWBAB-UHFFFAOYSA-N
Molecular Weight:603.74
Exact Mass:603.74
EC Number:203-194-7
NSC Number:760128
DSSTox ID:DTXSID9022655
Color/Form:Colorless to faintly yellow oil
ATC Code:R - Respiratory system
Categories:
Characteristics-
PSA:
121
XLogP3:1.2
Appearance:Liquid
Density:1.096±0.06 g/cm3(Predicted)
Boiling Point:649.0±55.0 °C(Predicted)
Flash Point:346.3ºC
Refractive Index:1.495
Water Solubility:soluble in most organic solvents except aliphatic hydrocarbons
Storage Conditions:Commercially available benzonatate liquid-filled capsules should be stored in tight, light-resistant containers at a controlled room temperature of 15-30 deg C.
Vapor Pressure:4.22X10-14 mm Hg at 25 deg C (est)
Toxicity:LD50 oral in mouse: 400mg/kg
Dissociation Constants:pKa = 3.03 (est)
Experimental Properties:Hydroxyl radical reaction rate constant = 1.49X10-10 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store in tight, light-resistant container as defined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
BBiochemicals,Peptides,Silicones,Pharmaceuticals,Building blocks,Intermediates
-
Location:
#101,Buliding1#,Jinsexixi,Xihu District,Hangzhou City, Zhejiang Province,CHINA
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
5
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
India
Benzonatate
100 MG May 8, 2024 Post an enquiry for this product
